PV
Providence Ventures
Venture CapitalActiveProvidence Ventures targets early-to mid-stage investment opportunities, preferring to be one of the first institutional investors.
17
Investments
10
Exits
$2.5B
AUM
58.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Providence Ventures.
Investment Thesis & Strategy
Providence Ventures invests in early-to mid-stage companies across asset management, business development, fintech, and venture capital, aiming to be a lead institutional investor.
Investment Activity
Deals per year over the last 7 years
5
20152
20161
20172
20180
20190
20202
2021Portfolio Companies
Selected investments from their portfolio of 17 companies
J
Jasper Therapeutics
Biotech · Series A, 2021
C
Cerebral
Healthcare · Series B, 2021
L
LetsGetChecked
Healthcare · Series A, 2018
M
Mindstrong Health
Healthcare · Series B, 2018
V
Viz.ai
Healthcare · Series A, 2017
P
PatientPop
Healthcare · Series B, 2016
L
Lyra Health
Healthcare · Series B, 2016
L
Livongo
Healthcare · Series C+, 2015
S
Signify Health
Healthcare · Series B, 2015
C
Collective Health
Healthcare · Series C+, 2015
B
BioIQ
Healthcare · Series B, 2015
W
Welltok
Healthcare · Series C+, 2015
Notable Exits
CompanyTypeYearValue / Acquirer
athenahealthAcquisition2023$17B
Signify HealthIPO2021$6.7B
Vivify HealthAcquisition2021—
AmwellIPO2020$4.1B
LivongoIPO2019$4.4B
Health CatalystIPO2019$1.1B
PhreesiaIPO2019$800M
Vascular TherapiesAcquisition2017—
Evolent HealthIPO2015$1.2B
Teladoc HealthIPO2015$750M
Frequently Asked Questions
Providence Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Madrona Venture Group
Seattle, United States · 359 deals
Vulcan Capital
Seattle, United States · 194 deals
Voyager Capital
Seattle, United States · 152 deals
OVP Venture Partners
Seattle, United States · 115 deals
Washington Research Foundation
Seattle, United States · 54 deals
Second Avenue Partners
Seattle, United States · 43 deals